NCT03065036View on ClinicalTrials.gov

Safety and Efficacy Study of the Hydrus Aqueous Implant in Subjects With POAG

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

November 30, 2013

Study Completion Date

February 28, 2014

Conditions
Primary Open Angle Glaucoma
Interventions
DRUG

prestudy topical glaucoma medications

Reintroduction of prestudy topical glaucoma medications, introduced one medication at a time during each study visit, as necessary.

Trial Locations (5)

10559

Berlin

55131

Universitatsmedizin der Johannes Gutenberg-Universitat Mainz Augenklinik und Poliklinik, Mainz

A-1090

University Medical Center Vienna, Vienna

Unknown

Aurelios Augenzentrum, Recklinghausen

Tijuana

Sponsors

Lead Sponsor

Ivantis, Inc.
All Listed Sponsors
lead

Ivantis, Inc.

INDUSTRY